Back
A
Anusak Kerdsin
national center genetic engineering & biotechnology (biotec)
31H-index
152Paper Count
2.9KCitation Count
Published Papers 75
Publication Date
Safety and Immunogenicity of an Additional Dose of Thailand Government Pharmaceutical Organization (GPO) Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Administered After Primary Vaccination with HXP-GPOVac or BNT162b2: An Open-Label Phase II Extension Trial in Thai Adults
Vaccines
IF3.4

